BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/10/2022 7:37:30 AM | Browse: 931 | Download: 1819
Publication Name World Journal of Gastrointestinal Endoscopy
Manuscript ID 69049
Country United States
ISSN 1948-5190 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget
Manuscript Source Invited Manuscript
All Author List Paulina Núñez F, Rodrigo Quera and David T Rubin
ORCID
Author(s) ORCID Number
Paulina Núñez F http://orcid.org/0000-0003-3727-1851
Rodrigo Quera http://orcid.org/0000-0001-5854-0526
David T Rubin http://orcid.org/0000-0001-5647-1723
Funding Agency and Grant Number
Corresponding Author David T Rubin, AGAF, FACG, MD, Chief Doctor, Medicine Inflammatory Bowel Disease Center, University of Chicago , 5841 S. Maryland Ave., MC4076, Room M410, Chicago, IL 60637, United States. drubin@medicine.bsd.uchicago.edu
Key Words Inflammatory bowel disease; Endoscopy; Crohn’s disease; Ulcerative colitis; Surveillance; Colorectal cancer
Core Tip Colorectal cancer (CRC) is one of the leading causes of death in inflammatory bowel disease (IBD) today. However, subsequent reports have shown lower rates of CRC. The expanding medical options in IBD have substantially improved our ability to control severe inflammation and likely to reduce the risk of CRC in this setting. We discuss the current evidence of the risks of developing CRC, and evaluate the best available strategies for detection and surveillance, as well as future opportunities for cancer prevention.
Publish Date 2022-02-10 07:37
Citation Núñez FP, Quera R, Rubin DT. Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget. World J Gastrointest Endosc 2022; 14(2): 85-95
URL https://www.wjgnet.com/1948-5190/full/v14/i2/85.htm
DOI https://dx.doi.org/10.4253/wjge.v14.i2.85
Full Article (PDF) WJGE-14-85.pdf
Full Article (Word) WJGE-14-85.docx